Market Signal Briefing

17h05 ▪
4
min read ▪ by
Ifeoluwa O.

Summarize this article with:

The cryptocurrency sector is closely watching the potential debut of the first spot XRP exchange-traded fund (ETF) following Nasdaq’s approval of Canary Capital’s XRP ETF listing. Analysts are anticipating that the ETF could begin trading as early as today, highlighting growing institutional interest and the prospect of broader market participation.

In brief

Analysts expect Canary Capital’s first US spot XRP ETF to begin trading as early as today following Nasdaq’s listing approval, pending final SEC authorization.
Other major XRP ETFs from Franklin Templeton, Bitwise, 21Shares, CoinShares, Grayscale, and WisdomTree are expected to launch later this month.

Nasdaq Confirms ETF Listing
Speculation around the XRP ETF increased on Wednesday when Nasdaq informed the U.S. Securities and Exchange Commission (SEC) that it had received a Form 8-A 12(b) application for Canary’s XRP ETF (XRPC). Alongside this filing, the exchange confirmed that the ETF had been approved for listing and registration, pending the official issuance notice.

Analysts reacted to the news, with Eric Balchunas, Senior ETF Analyst at Bloomberg, noting on X that the official listing notice for XRPC indicated a potential launch as early as today. Financial commentator Nate Geraci also pointed out that Canary had activated the ETF’s website, signaling that trading could begin soon.

Despite the excitement, the SEC has yet to grant final approval, which means the exact start of trading remains uncertain. Analysts have emphasized that Nasdaq’s notice is primarily procedural, confirming the exchange’s endorsement of the ETF and its filing with the SEC, rather than authorizing immediate trading. This highlights that additional regulatory steps may still be needed before the fund can be traded.

Projected Launches and Institutional Interest in XRP
Looking ahead, financial commentator Paul Barron outlined the upcoming schedule and management fees for XRP exchange-traded funds, projecting how major funds could enter the market:

Barron anticipates Canary Funds’ ETF will launch on November 13 with a 0.50% management fee.
He expects Franklin Templeton’s ETF to follow between November 14 and 18, with Bitwise Invest set for November 19–20, offering the lowest fee at 0.34%.
21Shares and CoinShares are projected to launch from November 20–22, followed by late-November rollouts from Grayscale (0.35% fee) and WisdomTree.
Barron highlighted that over $1.5 trillion in Wall Street assets could potentially flow into the XRP market, emphasizing the scale of institutional interest.

Following weeks of speculation, the anticipated XRP ETF launch received a boost after President Donald Trump signed legislation ending the longest government shutdown in U.S. history, as market observers awaited the SEC’s approval.

To provide context, earlier cryptocurrency exchange-traded funds, such as Bitcoin and Ether, began trading the day following SEC approval. More recently, ETFs for Solana, Litecoin, and Hedera became tradable the day after their exchange listings under updated regulatory processes, showing the current approach to crypto ETF listings.

The news surrounding Canary’s exchange-traded fund appears to have influenced XRP’s market performance. Over the past 24 hours, the token has risen more than 2%, reflecting growing investor optimism ahead of the expected trading debut.

Maximize your Cointribune experience with our "Read to Earn" program! For every article you read, earn points and access exclusive rewards. Sign up now and start earning benefits.

Join the program

A

A

Lien copié

Ifeoluwa O.

Ifeoluwa specializes in Web3 writing and marketing, with over 5 years of experience creating insightful and strategic content. Beyond this, he trades crypto and is skilled at conducting technical, fundamental, and on-chain analyses.

DISCLAIMER

The views, thoughts, and opinions expressed in this article belong solely to the author, and should not be taken as investment advice. Do your own research before taking any investment decisions.

The Czech National Bank (CNB) has purchased Bitcoin for the first time in its history to create a $1 million test portfolio. The pilot digital asset basket will also include a USD stablecoin and a tokenized deposit on the blockchain.

The CNB stated on November 13 that the bank’s board approved the purchase on October 30, following discussions about the possibility of investing in digital assets. However, the purpose of the portfolio is to gain practical Hodling experience and to test out the processes, hence the total amount invested will not be actively increased.

The bank’s analysis indicates that crypto is poised to become mainstream and may gain increasing acceptance in the future. In this light, the CNB said it intends to be prepared for this future. However, it clarified that it is not planning to add Bitcoin to its international reserves anytime soon. The bank’s board is yet to decide on the other investment classes covered in the analysis.

Michl claims the idea has stewed since January
Czech National Bank Governor Aleš Michl said he conceived the idea of a test portfolio at the beginning of this year. The aim was (and is) to try out “the decentralized” Bitcoin from the perspective of a central bank and evaluate its potential in diversifying the bank’s reserves. Hence, the bank’s board prepared the analysis report. 

Michl disclosed that subsequent internal meetings widened the scope to include the tokenization of assets and future payments. In effect, stablecoins and tokenized deposits were included alongside Bitcoin. Even CZ thinks they need some BNB.

“We will inform the public about our experience on an ongoing basis and present an overall assessment of the project in approximately two to three years.” 

–Aleš Michl, Governor of CNB

Michl explained that the central bank wants to test emerging methods of investing and paying, as these technologies are expected to expand in the near future. He added that it would be realistic to expect that, in the future, CNB will make it easy to buy tokenized Czech bonds using the Koruna.

CNB launches CNB Labs to test technologies
The Czech central bank has simultaneously launched the CNB Lab innovation hub to oversee the testing of technologies and trends impacting the financial market or monetary policy. Meanwhile, Michl emphasizes that CNB Lab is intended as a platform to gather experience and insights from testing various digital assets and blockchain solutions. 

The innovation hub will also experiment with AI tools, support innovations in payments, including instant payments, and undertake other projects related to the digitization of the financial sector. Michl says the idea is to gain hands-on experience, build professional capacity, and be as well prepared as possible for the future.

The CNB has also held bilateral consultations with ECB and IFM representatives on the statistical reporting of potential central bank Bitcoin holdings. However, all three agreed that directly held Bitcoin is not a reserve asset. 

Meanwhile, CNB stated that it will continue to hold Bitcoin for internal analysis. The aim is to test the whole chain of processes associated with the purchase, holding, and management of crypto.

CNB is looking to discover everything from the technical administration of keys and multi-level approval processes. The central bank also wants to test its response to crisis scenarios and security mechanisms to verify AML compliance.

Part of the testing at the CNB Lab will include comparing different types of digital assets and their various properties. The CNB will also test how to use and settle the digital assets in trading scenarios.

It will also record them in its accounts and audit their holdings. The bank’s board decided it is essential to maintain and develop in-house expertise. Practical experience will enable CNB staff to gain and transfer knowledge across teams and departments.   

Sign up to Bybit and start trading with $30,050 in welcome gifts

TL;DR

Canary Capital launched the first spot XRP ETF on Nasdaq, providing regulated exposure to Ripple’s native token.
The fund opened at $40 and traded around $26.30, giving institutional investors access to the token without holding assets or using exchanges.
The firm highlighted the efficiency of the XRP Ledger and its role in global payments, positioning the ETF as a bridge between blockchain and traditional finance.

The first spot XRP ETF debuted today on Wall Street, marking a structural shift in the relationship between traditional markets and the crypto industry. The fund, launched by Canary Capital under the ticker XRPC, began trading on Nasdaq and offers regulated exposure to Ripple’s native token.

The ETF opened at $40 and stabilized around $26.30 in its first hours of trading. It provides institutional investors with direct access to token performance without needing to use exchanges or manage custody of the assets. Canary explained that the product was designed for investors seeking exposure to the network’s real-world utility, focused on international payments and liquidity provision.

XRPL: Moving Capital as Easily as Sending an Email
The XRP Ledger has been operating since 2012, processing near-instant transactions with minimal energy consumption. Its infrastructure enables cross-border transfers and settlements, asset tokenization, and support for liquidity protocols. The firm emphasized that this architecture, designed to move value as easily as sending an email, underpins the asset’s longevity and stability.

The launch was interpreted as the start of a new phase of price discovery for XRP within formal regulatory frameworks. Analysts noted that the impact would not be immediate, but institutional inflows could gradually alter market dynamics. During the session, XRP traded near $2.47, with technical indicators showing a balance between buyers and sellers.

Canary described XRPC as a bridge between distributed finance and traditional infrastructure. The firm considers the token’s technical maturity and enterprise adoption to place it in a different category from the rest of the crypto market. Its strategy is based on the premise that assets with payment and settlement utility will lead the next phase of blockchain adoption.

The fund is not registered under the Investment Company Act of 1940 and therefore does not follow the requirements of traditional ETFs. Canary warns that investing in XRPC carries substantial risks, including volatility, liquidity constraints, and potential regulatory changes. Still, the ETF’s launch opens a new institutional channel for the Ripple ecosystem and redefines its role within the global financial system

XRP price is failing to reclaim the 200-day moving average, showing clear signs of buyer exhaustion as weakness builds and downside risk toward the $2.20 support continues to grow.

Summary

XRP repeatedly fails to reclaim the 200 MA, confirming ongoing weakness.
Low-volume bounce suggests sellers remain in control near $2.72 resistance.
Downside risk elevated, with $2.20 support likely to be retested next.

Ripple (XRP) price is showing increasing signs of weakness as the price continues to struggle beneath the 200-day moving average, a level that has repeatedly acted as a significant resistance barrier throughout the recent downtrend.

The most recent attempt to reclaim this level resulted in another harsh rejection, highlighting a lack of bullish conviction and raising concerns of a continued decline toward lower support levels. With bearish momentum building, market participants are watching closely to determine whether XRP can stabilize or whether further downside is imminent.

XRP price key technical points:

Major Resistance: The 200 MA aligns with the $2.72 resistance zone, 0.618 Fibonacci, and value area low.
Primary Support: $2.20 remains the crucial high-timeframe support preventing a deeper breakdown.
Weak Bounce: Recent upside movement is low-volume, resembling an oversold bounce rather than a reversal.

XRPUSDT (1D) Chart, Source: TradingView
XRP’s recent price behavior reflects a classic sign of market exhaustion. After failing to reclaim the 200-day moving average, the asset produced a new swing low, solidifying the broader bearish market structure. Although price has initiated a temporary bounce, the move carries clear signs of weakness, most notably the declining volume that indicates buyers are not stepping in with conviction.

The $2.72 resistance zone remains a major technical hurdle. This level carries multiple confluences: the 200-day moving average, the 0.618 Fibonacci retracement, and the value area low from the previous range. Historically, zones with overlapping technical resistance often produce strong rejections, and XRP has already shown multiple failed attempts in this region.

The current bounce toward resistance appears more corrective than impulsive, suggesting that the broader downtrend remains intact. Unless bulls push XRP above the 200 MA with strong volume, another rejection is likely, confirming a lower high and signaling a continuation toward lower support.

A move back to the key $2.20 support remains the most probable outcome if weakness persists. This region previously halted aggressive downside and must hold again to prevent a deeper capitulation move. A decisive close below $2.20 would open the door for further declines and potentially a retest of even lower liquidity pockets.

What to expect in the coming price action
XRP must reclaim $2.72 and the 200 MA to neutralize ongoing bearish momentum. Failure to break this resistance increases the likelihood of a return to $2.20 support, with further downside risk still dominant.

Emory University Doubles Down on Bitcoin With $52M Grayscale BTC ETF StakeThe managers of the Georgia university's endowment are showing an inclination towards hard assets, opening a sizable position in a gold ETF as well. Nov 13, 2025, 4:21 p.m.

Emory University tiptoed further into bitcoin BTC$103,539.43 during the third quarter.

The private research university based in Georgia reported holding over 1 million shares of the Grayscale Bitcoin Mini Trust as Sept. 30, according to a 13F filing Thursday. That stake was worth roughly nearly $52 billion at that time, though sizably less now at current prices. The school held just under 500,000 shares of the fund at the end of the second quarter.

STORY CONTINUES BELOW

The university first disclosed a position in Grayscale’s trust in October 2024, then valued at just over $15 million.

Emory's far smaller position in BlackRock's spot bitcoin ETF was unchanged during the third quarter and valued at just about $290,000.

The endowment managers' interest in hard assets was also reflected in a new move into BlackRock's iShares Gold Trust (IAU), with nearly a $79 million stake in that fund as of the end of the third quarter.

The university’s endowment also modestly increased its equity stake in crypto exchange Coinbase (COIN). It now holds nearly 4,500 shares worth close to $1.2 million, up slightly from the 4,312 shares it’s held since last year.

Endowments are long-term investment funds typically set up to support non-profits like universities, hospitals or religious institutions. Like pension funds, they tend to favor relatively conservative strategies, which makes their increasing interest in bitcoin through regulated ETFs a noteworthy shift.

Emory’s broader embrace of bitcoin ETFs could be seen as part of a slow but steady thaw among institutional investors. While still a small piece of its overall portfolio, the size and pace of Emory’s bitcoin allocations signal a rising comfort level with the asset — especially when held in familiar wrappers like ETFs.

AI Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.

More For You

OwlTing: Stablecoin Infrastructure for the Future

Oct 16, 2025

Stablecoin payment volumes have grown to $19.4B year-to-date in 2025. OwlTing aims to capture this market by developing payment infrastructure that processes transactions in seconds for fractions of a cent.

View Full Report

More For You

BONK Falls 3.9%, Sliding Below Support

18 minutes ago

BONK dropped 3.9% to $0.00001223 as volume nearly doubled amid a breakdown through key support levels.

What to know:

BONK declined 3.9% to $0.00001223 amid renewed selling pressure.Trading volume surged 96% above the 24-hour average during the breakdown.Support at $0.00001211 failed, establishing new resistance near $0.00001226.Read full story

TL;DR

Aztec Network launches token sale using a novel auction system.
The auction offers a seventy-five percent discount on valuation.
It uses zero-knowledge proofs for private compliance verification.

Aztec Network, a privacy-focused Layer 2 network built on Ethereum, announced it will conduct its token sale using the Continuous Clearing Auction (CCA) system developed by Uniswap Labs, with Aztec as a core contributor. Registration opened Thursday at 10 a.m. EST, with public bidding running from December 2 to December 6, 2025.

The auction starts at a fully diluted valuation (FDV) of $350 million, representing a 75% discount from Aztec Labs’ last funding round. Participation limits are set per user to prevent large investors from dominating the sale. According to project leaders, Aztec is the first protocol to implement CCA, enabling real-time bids through on-chain smart contracts, with open and transparent access for any participant.

Privacy and Fairness Drive Aztec’s New Offering
The initiative responds to growing concerns in DeFi about privacy and the security of personal data. Recent incidents, such as the Balancer hack, and the rise of projects like Zcash, have highlighted the need for systems that protect user information while maintaining transparency and fairness in token sales.

Joe Andrews, co-founder and president of Aztec Labs, stated that CCA redefines fair access in crypto, removing special deals and hidden allocations. “Now we have a permissionless and non-custodial system on Ethereum that is transparent, fair, and immutable,” he explained.

The sale will also use zero-knowledge proofs through ZkPassport’s Noir circuits, allowing compliant sanctions checks without exposing sensitive passport data in centralized databases. Participants can verify their eligibility and mint a soulbound NFT confirming their right to bid before the auction begins.

Aztec officially launched its public testnet on May 1, offering what the team describes as the first fully programmable privacy solution on blockchain. The company completed a $100 million Series B funding round led by a16z, reinforcing its ability to build infrastructures that combine privacy and transparency.

With this strategy, Aztec Network aims to set a standard in token sales, combining equitable access, security, and programmable privacy, marking a key step in the evolution of DeFi on Ethereum.

TLDR

Tether supported a major operation that seized 12 million USDT, valued at 400 million baht.
The joint operation led to the arrest of 73 suspects, including 22 foreign nationals.
Authorities confiscated over 522 million baht in assets during the operation in Southeast Asia.
Tether has assisted in blocking illicit funds and facilitating digital asset seizures globally.
Tether’s efforts have led to freezing over $3.2 billion in illicit assets across 59 jurisdictions.

Tether has provided support in a coordinated international operation between the Royal Thai Police and the U.S. Secret Service. The operation led to the seizure of approximately 12 million USDT, valued at roughly 400 million Thai baht. This action dismantled a major transnational fraud network operating across Southeast Asia. The collaborative effort targeted online fraud and money laundering schemes connected to the digital asset industry.

Key Operation Details
The operation, which was led by Thailand’s Technology Crime Suppression Division (TCSD) under the Ministry of Digital Economy and Society, resulted in the arrest of 73 individuals. Among them, 22 were foreign nationals, while the remaining 51 were Thai citizens. Authorities also confiscated assets worth over 522 million baht, further disrupting the operations of the criminal network.

The seizure of USDT is part of an ongoing effort to combat illicit activity in the digital asset space. The operation marks a significant step in addressing the growing concern over fraud and money laundering tied to cryptocurrencies and other digital assets.

Tether’s Role in Combating Financial Crime
Tether’s involvement in this case underscores its ongoing commitment to assisting law enforcement agencies around the world. In recent months, Tether has worked with several agencies to block illicit funds and facilitate the seizure of digital assets tied to criminal activity. In addition to this Thai operation, Tether has assisted in major law enforcement actions, including a significant seizure involving $225 million in USDT last year.

Tether’s efforts are aligned with its broader strategy of ensuring transparency and accountability in the digital asset sector. The company has been proactive in working with more than 290 law enforcement agencies across 59 jurisdictions, resulting in the blocking of over $3.2 billion in illicit assets. This cooperation is crucial in reducing the potential misuse of digital currencies. This operation is another example of Tether’s ongoing collaboration with international law enforcement. The company continues to assist authorities in freezing illicit assets, protecting victims, and strengthening the integrity of blockchain-based financial systems.

21Shares debuts two crypto index funds offering exposure to Bitcoin, Dogecoin and morePolicy
• November 13, 2025, 11:28AM EST

Partner offers

The Block may may earn a commission if you use our partner offers, at no extra cost to you.

Quick Take
The 21Shares FTSE Crypto 10 Index ETF, ticker symbol TTOP, and the 21Shares FTSE Crypto 10 ex-BTC Index ETF, ticker symbol TXBC, debuted on Thursday.
Both were the first crypto index ETFs to be registered under the Investment Company Act of 1940 to launch, 21Shares said in a statement.
Cryptocurrency exchange-traded fund provider 21Shares launched two crypto index ETFs, providing investors with exposure to bitcoin, Solana, Ethereum, and Dogecoin.

The firm launched the 21Shares FTSE Crypto 10 Index ETF, ticker symbol TTOP, and the 21Shares FTSE Crypto 10 ex-BTC Index ETF, ticker symbol TXBC, on Thursday. Both were the first crypto index ETFs to be registered under the Investment Company Act of 1940 to launch, 21Shares said in a statement.

"Many of our clients have asked for a simple, regulated way to access the market as a whole rather than choosing individual tokens," said Federico Brokate, global head of business development at 21Shares, in the statement. "With TTOP and TXBC, we’re bringing that familiar, diversified approach to digital assets, giving investors a single point of access to a broad set of leading cryptocurrencies within a structure designed to adjust as the market evolves."

The 21Shares FTSE Crypto 10 Index ETF has a management fee of 0.50% and tracks a "market cap-weighted index" of the 10 biggest cryptocurrencies. Meanwhile, the 21Shares FTSE Crypto 10 ex-BTC Index ETF has a management fee of 0.65% and invests just in crypto and blockchain networks "that focus on real-world applications beyond Bitcoin’s macro hedge proposition." 21Shares launched both those ETFs with adviser Teucrium, according to the statement.

Firms looking to launch crypto ETFs either try to list through the Investment Company Act of 1940 or the Securities Act of 1933. The 1940 Act regulates investment funds that pool capital from investors to pursue a common investment strategy in an effort to protect investors from conflicts of interest and fraud.

Disclaimer: The Block is an independent media outlet that delivers news, research, and data. As of November 2023, Foresight Ventures is a majority investor of The Block. Foresight Ventures invests in other companies in the crypto space. Crypto exchange Bitget is an anchor LP for Foresight Ventures. The Block continues to operate independently to deliver objective, impactful, and timely information about the crypto industry. Here are our current financial disclosures.

© 2025 The Block. All Rights Reserved. This article is provided for informational purposes only. It is not offered or intended to be used as legal, tax, investment, financial, or other advice.

TAGS

AUTHOR Sarah is a reporter at The Block covering policy, regulation and legal happenings. Before, Sarah was a reporter with CQ Legal writing about securities regulation, which is where she first started reporting on crypto. Sarah has also written for The Bond Buyer and American Banker, among other finance-related publications. She graduated from the University of Missouri and earned a degree in print and digital journalism. Sarah is based in Washington D.C., and is an avid coffee lover. You can follow her on Twitter @ForTheWynn. See More

WHO WE ARE The Block is a news provider that strives to be the first and final word on digital assets news, research, and data. +
Follow us on Google News
More by Sarah Wynn

As Cardano posts new ecosystem milestones, the network is seeing higher activity and fresh technical signals. The Cardano Card launch, rising address metrics and a falling-wedge setup shape the latest overview.

EMURGO and Wirex launch first Cardano Card at Berlin summitEMURGO and digital payments firm Wirex have launched the first “Cardano Card” at the Cardano Summit 2025, introducing an ADA-branded multi-chain crypto card inside the Wirex app for users in supported markets.

The card is integrated natively in the Wirex app and becomes available to more than six million Wirex customers across 130 countries, allowing them to spend ADA alongside other cryptocurrencies and stablecoins wherever Visa is accepted. Attendees at the Berlin summit are the first to see physical plastic and metal versions and can register for virtual cards at an on-site booth.

Cardano Card Physical Edition. Source: Cardanians on X

Cardano Card users can pay online and in stores with over 685 supported digital assets, including ADA, Bitcoin, Ether and USDC. They also gain access to Wirex features such as crypto cashback on purchases, referral rewards, ATM use and foreign exchange services. A portion of profits from the product is intended for the Cardano Treasury, according to the announcement.

The partners plan a second phase in 2026 that will introduce a non-custodial version of the Cardano Card. That product is expected to offer similar functions — including yield, borrowing and lending tools for ADA and other assets — while keeping users in control of their private keys.

Wirex says it has processed about $20 billion in crypto transactions and supports more than 150 traditional and digital assets. The companies cite industry estimates of over 820 million active wallets and roughly 31 million crypto wallets already used for day-to-day payments as a sign that there is room for further card-based spending of digital assets.

Cardano sees daily active addresses rise 19.2% while transactions jump 15.7%In Q3 2025, the Cardano network recorded a 19.2% increase quarter-on-quarter in average daily active addresses. At the same time, daily transactions rose by 15.7%.

Cardano Daily Active Addresses and Transactions. Source: Messari

The report shows sustained growth in user engagement. As the number of unique addresses interacting on-chain climbed, the transaction count followed suit. This signals deeper participation rather than just price-driven activity.

Moreover, the rise in active addresses and transactions comes amid other ecosystem gains such as a 28.7% increase in DeFi total value locked and a market cap rise of 42.5%.

Analyst spots RSI reset and falling wedge on CardanoMeanwhile, technical analyst The DApp Analyst reports that Cardano’s ADA daily relative strength index has reset to the same zone seen in July, when the token later gained about 97% over 54 days. The new RSI trough appears after a steady pullback, with ADA still trading below key moving averages on the daily chart.

Cardano Daily Chart. Source: The DApp Analyst on X

At the same time, his chart shows a falling wedge pattern on the daily timeframe, with price moving between two converging downward trendlines. The setup places ADA near the middle of the structure while RSI turns higher from low levels, hinting that selling pressure may be easing.

The DApp Analyst presents the pattern as a work in progress and asks followers what they expect next. Traders watching this view will likely track whether ADA can close above the upper wedge boundary or instead drift back toward the lower line, which would weaken the bullish case.

Analyst’s Disclosure:I/we have a beneficial long position in the shares of CRWV, NBIS, META, NVDA, IREN either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

-

The Yeti is partnering with KANE Footwear on the Revive AC, the toughest recovery shoe for all environments

WESTPORT, Conn.--(BUSINESS WIRE)--KANE Footwear, a leader in the active recovery footwear industry, today announced its official partnership with Yeti Boo as an addition to the KANE Athlete roster, which includes ultra marathoner and Jelly Roll’s running coach, Matt Johnson, Peloton instructor and animal rights activist, Olivia Amato and more. This partnership is a result of substantial testing and organic interest from the Yeti in the KANE Revive AC, the world’s toughest recovery shoe.

KANE Footwear created a custom size 43 Revive AC for extensive Yeti wear testing in an undisclosed location. The testing included wandering for days, running from hikers, snowball fights, and sleeping in below-freezing temperatures.

'I've really put the Revive AC to the test," says Yeti Boo. “As an all-conditions athlete, it doesn’t matter if there are blizzards, ice storms, or avalanches – recovery remains my priority so I can stay jacked. No other recovery shoe is built for the snow, sleet, rain, mud, and cold while keeping me comfortable all-day as I explore the woods for hundreds of miles.”

The Yeti-approved KANE Revive AC is designed on the foundation of the crowd favorite KANE Revive, with enhanced all-conditions features, including:

A rubberized outsole provides superior traction, with 2.65mm treads for traversing icy, mountainous terrain.

A sewn-in neoprene collar that locks in warmth while shielding against the elements, including snowballs.

Nylon grosgrain tabs at the front and back for easy on-and-off wear, featuring reflective detailing on the front tab that will make passerbys say, “Did you just see that?”

A debossed hole pattern on the upper to promote breathability and ensure a dry environment to protect fur from getting wet.

Raised footbed nodes to activate blood flow and pressure points allowing even the biggest feet and legs to recover.

Lightweight slip-on design that comfortably captures heel, arch and instep for all-day outdoor support.

“At KANE Footwear, we believe recovery should never be limited by weather,” says John Gagliardi, Founder and CEO of KANE Footwear. “KANE is the first to bring recovery footwear to those in cold, wet environments, and we will continue innovating the recovery footwear industry to make recovery accessible for all.”

The world’s toughest recovery shoe is available for purchase at kanefootwear.com and retails for $120. To stay up-to-date on Yeti Boo’s KANE Footwear journey, follow KANE Footwear @kanefootwear and Yeti Boo @yeti.vlogs on social media.

About KANE Footwear

KANE is a footwear brand dedicated to the recovery of the body and planet. Implementing expert-driven design, biobased manufacturing, and modern aesthetics, KANE is creating active recovery footwear for mindful movers. The KANE Footwear Collection, designed in collaboration with board-certified foot and ankle surgeon Dr. Daniel Geller, are the first shoes designed specifically for active recovery. The KANE Revive and Revive AC are made with bio-based RestoreFoam™, created from Brazilian sugarcane, and integrate principles of active recovery to renew the body through stimulation, circulation and blood flow. KANE is a Certified B Corporation and a proud member of 1% for the Planet. KANE was founded by former pro athlete, John Gagliardi, who was inspired to create a performance EVA product that professional athletes and active people can use year-round. KANE was founded in 2021 and is headquartered in Westport, CT. You can learn more at www.kanefootwear.com.

KANE Revive AC Imagery: HERE

KANE x Yeti Boo Imagery: HERE

More News From KANE Footwear

Back to Newsroom

The recommendations of Wall Street analysts are often relied on by investors when deciding whether to buy, sell, or hold a stock. Media reports about these brokerage-firm-employed (or sell-side) analysts changing their ratings often affect a stock's price. Do they really matter, though?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about PDD Holdings Inc. Sponsored ADR (PDD - Free Report) .

PDD Holdings Inc. Sponsored ADR currently has an average brokerage recommendation (ABR) of 1.84, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 19 brokerage firms. An ABR of 1.84 approximates between Strong Buy and Buy.

Of the 19 recommendations that derive the current ABR, 11 are Strong Buy, representing 57.9% of all recommendations.

Brokerage Recommendation Trends for PDD

Check price target & stock forecast for PDD Holdings Inc. Sponsored ADR here>>>

The ABR suggests buying PDD Holdings Inc. Sponsored ADR, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Should You Invest in PDD?In terms of earnings estimate revisions for PDD Holdings Inc. Sponsored ADR, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $9.62.

Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for PDD Holdings Inc. Sponsored ADR. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for PDD Holdings Inc Sponsored ADR.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Let's take a look at what these Wall Street heavyweights have to say about Rio Tinto (RIO - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Rio Tinto currently has an average brokerage recommendation (ABR) of 1.88, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 16 brokerage firms. An ABR of 1.88 approximates between Strong Buy and Buy.

Of the 16 recommendations that derive the current ABR, nine are Strong Buy, representing 56.3% of all recommendations.

Brokerage Recommendation Trends for RIO

Check price target & stock forecast for Rio Tinto here>>>

The ABR suggests buying Rio Tinto, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Is RIO a Good Investment?Looking at the earnings estimate revisions for Rio Tinto, the Zacks Consensus Estimate for the current year has increased 0.9% over the past month to $6.09.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #2 (Buy) for Rio Tinto. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Rio Tinto may serve as a useful guide for investors.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Let's take a look at what these Wall Street heavyweights have to say about Take-Two Interactive (TTWO - Free Report) before we discuss the reliability of brokerage recommendations and how to use them to your advantage.

Take-Two currently has an average brokerage recommendation (ABR) of 1.32, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 28 brokerage firms. An ABR of 1.32 approximates between Strong Buy and Buy.

Of the 28 recommendations that derive the current ABR, 22 are Strong Buy and three are Buy. Strong Buy and Buy respectively account for 78.6% and 10.7% of all recommendations.

Brokerage Recommendation Trends for TTWO

Check price target & stock forecast for Take-Two here>>>

The ABR suggests buying Take-Two, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

On the other hand, earnings estimate revisions are at the core of the Zacks Rank. And empirical research shows a strong correlation between trends in earnings estimate revisions and near-term stock price movements.

In addition, the different Zacks Rank grades are applied proportionately to all stocks for which brokerage analysts provide current-year earnings estimates. In other words, this tool always maintains a balance among its five ranks.

There is also a key difference between the ABR and Zacks Rank when it comes to freshness. When you look at the ABR, it may not be up-to-date. Nonetheless, since brokerage analysts constantly revise their earnings estimates to reflect changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in predicting future stock prices.

Is TTWO Worth Investing In?Looking at the earnings estimate revisions for Take-Two, the Zacks Consensus Estimate for the current year has increased 5.8% over the past month to $2.89.

Analysts' growing optimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates higher, could be a legitimate reason for the stock to soar in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #1 (Strong Buy) for Take-Two. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, the Buy-equivalent ABR for Take-Two may serve as a useful guide for investors.

When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts often influence a stock's price, but are they really important?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Adobe Systems (ADBE - Free Report) .

Adobe currently has an average brokerage recommendation (ABR) of 1.89, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 38 brokerage firms. An ABR of 1.89 approximates between Strong Buy and Buy.

Of the 38 recommendations that derive the current ABR, 22 are Strong Buy and two are Buy. Strong Buy and Buy respectively account for 57.9% and 5.3% of all recommendations.

Brokerage Recommendation Trends for ADBE

Check price target & stock forecast for Adobe here>>>

The ABR suggests buying Adobe, but making an investment decision solely on the basis of this information might not be a good idea. According to several studies, brokerage recommendations have little to no success guiding investors to choose stocks with the most potential for price appreciation.

Do you wonder why? As a result of the vested interest of brokerage firms in a stock they cover, their analysts tend to rate it with a strong positive bias. According to our research, brokerage firms assign five "Strong Buy" recommendations for every "Strong Sell" recommendation.

This means that the interests of these institutions are not always aligned with those of retail investors, giving little insight into the direction of a stock's future price movement. It would therefore be best to use this information to validate your own analysis or a tool that has proven to be highly effective at predicting stock price movements.

With an impressive externally audited track record, our proprietary stock rating tool, the Zacks Rank, which classifies stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), is a reliable indicator of a stock's near-term price performance. So, validating the Zacks Rank with ABR could go a long way in making a profitable investment decision.

Zacks Rank Should Not Be Confused With ABRAlthough both Zacks Rank and ABR are displayed in a range of 1--5, they are different measures altogether.

The ABR is calculated solely based on brokerage recommendations and is typically displayed with decimals (example: 1.28). In contrast, the Zacks Rank is a quantitative model allowing investors to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

Analysts employed by brokerage firms have been and continue to be overly optimistic with their recommendations. Since the ratings issued by these analysts are more favorable than their research would support because of the vested interest of their employers, they mislead investors far more often than they guide.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Is ADBE a Good Investment?In terms of earnings estimate revisions for Adobe, the Zacks Consensus Estimate for the current year has remained unchanged over the past month at $20.77.

Analysts' steady views regarding the company's earnings prospects, as indicated by an unchanged consensus estimate, could be a legitimate reason for the stock to perform in line with the broader market in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #3 (Hold) for Adobe. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

It may therefore be prudent to be a little cautious with the Buy-equivalent ABR for Adobe.

For the quarter ended September 2025, Spectrum Brands (SPB - Free Report) reported revenue of $733.5 million, down 5.2% over the same period last year. EPS came in at $2.61, compared to $0.97 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $744.93 million, representing a surprise of -1.53%. The company delivered an EPS surprise of +238.96%, with the consensus EPS estimate being $0.77.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Spectrum performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Home & Personal Care (HPC): $296.2 million versus $314.5 million estimated by two analysts on average. Compared to the year-ago quarter, this number represents a -11.9% change.Net Sales- Home & Garden (H&G): $139.2 million compared to the $147.55 million average estimate based on two analysts. The reported number represents a change of +3.2% year over year.Net Sales- Global Pet Care (GPC): $298.1 million compared to the $291.95 million average estimate based on two analysts. The reported number represents a change of -1.5% year over year.View all Key Company Metrics for Spectrum here>>>

Shares of Spectrum have returned +3.3% over the past month versus the Zacks S&P 500 composite's +4.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Edgewell Personal Care (EPC - Free Report) reported $537.2 million in revenue for the quarter ended September 2025, representing a year-over-year increase of 3.8%. EPS of $0.68 for the same period compares to $0.72 a year ago.

The reported revenue compares to the Zacks Consensus Estimate of $536.03 million, representing a surprise of +0.22%. The company delivered an EPS surprise of -17.07%, with the consensus EPS estimate being $0.82.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how Edgewell Personal performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

Net Sales- Feminine Care: $67.3 million compared to the $67.62 million average estimate based on three analysts. The reported number represents a change of +0.9% year over year.Net Sales- Wet Shave: $321.9 million versus $328.88 million estimated by three analysts on average. Compared to the year-ago quarter, this number represents a +1.2% change.Net Sales- Sun and Skin Care: $148 million versus the three-analyst average estimate of $139.53 million. The reported number represents a year-over-year change of +11.5%.View all Key Company Metrics for Edgewell Personal here>>>

Shares of Edgewell Personal have returned -6.2% over the past month versus the Zacks S&P 500 composite's +4.6% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.

Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?

Before we discuss the reliability of brokerage recommendations and how to use them to your advantage, let's see what these Wall Street heavyweights think about Lowe's (LOW - Free Report) .

Lowe's currently has an average brokerage recommendation (ABR) of 1.85, on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell, etc.) made by 31 brokerage firms. An ABR of 1.85 approximates between Strong Buy and Buy.

Of the 31 recommendations that derive the current ABR, 18 are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 58.1% and 3.2% of all recommendations.

Brokerage Recommendation Trends for LOW

Check price target & stock forecast for Lowe's here>>>

While the ABR calls for buying Lowe's, it may not be wise to make an investment decision solely based on this information. Several studies have shown limited to no success of brokerage recommendations in guiding investors to pick stocks with the best price increase potential.

Are you wondering why? The vested interest of brokerage firms in a stock they cover often results in a strong positive bias of their analysts in rating it. Our research shows that for every "Strong Sell" recommendation, brokerage firms assign five "Strong Buy" recommendations.

In other words, their interests aren't always aligned with retail investors, rarely indicating where the price of a stock could actually be heading. Therefore, the best use of this information could be validating your own research or an indicator that has proven to be highly successful in predicting a stock's price movement.

Zacks Rank, our proprietary stock rating tool with an impressive externally audited track record, categorizes stocks into five groups, ranging from Zacks Rank #1 (Strong Buy) to Zacks Rank #5 (Strong Sell), and is an effective indicator of a stock's price performance in the near future. Therefore, using the ABR to validate the Zacks Rank could be an efficient way of making a profitable investment decision.

ABR Should Not Be Confused With Zacks RankIn spite of the fact that Zacks Rank and ABR both appear on a scale from 1 to 5, they are two completely different measures.

Broker recommendations are the sole basis for calculating the ABR, which is typically displayed in decimals (such as 1.28). The Zacks Rank, on the other hand, is a quantitative model designed to harness the power of earnings estimate revisions. It is displayed in whole numbers -- 1 to 5.

It has been and continues to be the case that analysts employed by brokerage firms are overly optimistic with their recommendations. Because of their employers' vested interests, these analysts issue more favorable ratings than their research would support, misguiding investors far more often than helping them.

In contrast, the Zacks Rank is driven by earnings estimate revisions. And near-term stock price movements are strongly correlated with trends in earnings estimate revisions, according to empirical research.

Furthermore, the different grades of the Zacks Rank are applied proportionately across all stocks for which brokerage analysts provide earnings estimates for the current year. In other words, at all times, this tool maintains a balance among the five ranks it assigns.

Another key difference between the ABR and Zacks Rank is freshness. The ABR is not necessarily up-to-date when you look at it. But, since brokerage analysts keep revising their earnings estimates to account for a company's changing business trends, and their actions get reflected in the Zacks Rank quickly enough, it is always timely in indicating future price movements.

Should You Invest in LOW?In terms of earnings estimate revisions for Lowe's, the Zacks Consensus Estimate for the current year has declined 0.1% over the past month to $12.3.

Analysts' growing pessimism over the company's earnings prospects, as indicated by strong agreement among them in revising EPS estimates lower, could be a legitimate reason for the stock to plunge in the near term.

The size of the recent change in the consensus estimate, along with three other factors related to earnings estimates, has resulted in a Zacks Rank #4 (Sell) for Lowe's. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Therefore, it could be wise to take the Buy-equivalent ABR for Lowe's with a grain of salt.

Key Takeaways NVDA, DELL, PLTR, FICO and GWRE are top big data picks with growth potential.
NVDA leads AI infrastructure; DELL, PLTR, FICO and GWRE show strong earnings and innovation momentum.
Consensus estimates and target prices for all five firms signal solid upside opportunities ahead.

Big Data refers to a vast and diverse collection of structured, unstructured and semi-structured data that inundates businesses on a day-to-day basis. The big data space focuses on companies that process, store and analyze data, and provide data mining, transformation, visualization and predictive analytics tools.

Here, we have selected five such companies — NVIDIA Corp. (NVDA - Free Report) , Dell Technologies Inc. (DELL - Free Report) , Palantir Technologies Inc. (PLTR - Free Report) , Fair Isaac Corp. (FICO - Free Report) and Guidewire Software Inc. (GWRE - Free Report) . Each of our picks currently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Utility of Big DataBig Data is utilized in advanced analytics applications like predictive modeling and machine learning to solve business problems and make informed decisions. The latest high-end digital mobility advancements, including the Internet of Things (IoT) and artificial intelligence (AI), have led to rapid growth in data. Consequently, new big data tools have emerged to collect, process, and analyze data to derive maximum value out of it.

Big data offers corporations better decision-making and risk-management abilities. It has also increased agility and innovation, making operations more efficient and effective in improving customer experiences. 

The chart below shows the price performance of our five picks in the past three months.

Image Source: Zacks Investment Research

NVIDIA Corp.NVIDIA — the undisputed global leader of generative artificial intelligence (AI)-powered graphical processing units (GPUs) — has been benefiting from the booming data center business, which continues to power the company’s growth amid the global buildout of AI infrastructure. This massive demand is fueled by strong demand from hyperscalers, AI model developers and enterprise customers expanding their AI infrastructure.

The ongoing ramp-up of the Blackwell architecture is central to NVDA’s momentum. The GB300 systems, which offer higher performance and improved energy efficiency compared to the previous Hopper generation, are now being shipped in large volumes. 

Customers are using these systems to support complex AI workloads, from large language models to real-time inference. NVDA reaffirmed its commitment to continued innovation, evolution and execution. NVDA’s full-stack approach, which combines GPUs, networking and software, continues to make it the preferred partner for large-scale AI projects.

NVIDIA has an expected revenue and earnings growth rate of 33% and 40%, respectively, for next year (ending January 2027). The Zacks Consensus Estimate for next year’s earnings has improved 0.6% over the last 30 days. 

The short-term average price target of brokerage firms for the stock represents an increase of 20.8% from the last closing price of $193.80. The brokerage target price is currently in the range of $100-$350. This indicates a maximum upside of 80.6% and a downside of 48.4%.

Dell Technologies Inc.Dell Technologies has been benefiting from strong demand for AI servers driven by ongoing digital transformation and heightened interest in generative AI applications. In the last reported quarter, DELL secured $8.2 billion in AI server orders, surpassing shipments and building a strong backlog. 

DELL’s PowerEdge XE9680L AI-optimized server is in high demand. Strong enterprise demand for AI-optimized servers is aiding the company. A robust partner base, which includes the likes of NVIDIA, Alphabet and Microsoft has been a major growth driver. 

DELL is expanding its cloud services through its infrastructure solutions and rich partner base that provides essential hardware and services that support cloud environments. Through its APEX platform, DELL provides multi-cloud solutions and advanced AI infrastructure, which have become the key highlights of its offerings.

Dell Technologies has an expected revenue and earnings growth rate of 7% and 18.4%, respectively, for next year (ending January 2027). The Zacks Consensus Estimate for next year’s earnings has improved 1.2% over the last 30 days. 

The short-term average price target of brokerage firms for the stock represents an increase of 17.9% from the last closing price of $140.71. The brokerage target price is currently in the range of $130-$200. This indicates a maximum upside of 42.1% and a downside of 7.6%.

Palantir Technologies Inc. Palantir Technologies’ AI strategy is comprehensive, combining its proprietary Foundry and Gotham platforms with a solid plan to promote AI adoption across both government and commercial sectors. PLTR’s AI Platform (AIP) is the backbone of these capabilities, enabling organizations to process large datasets and derive real-time insights. This is especially valuable in sectors requiring extensive data integration, such as defense, healthcare, finance and intelligence, where operational efficiency and decision-making speed are critical. 

In the government sector, PLTR is aligning its AI strategy with U.S. defense priorities. Its work in high-profile initiatives, such as the Department of Defense’s Open DAGIR project, highlight its ability to modernize military operations through AI-driven solutions where data interoperability and real-time decision-making capabilities are imperative. These capabilities solidify PLTR’s position as a key player in the defense sector. 

In the commercial space, PLTR’s AIP boot camps — providing hands-on experience to over 1,000 companies — have proven instrumental in customer acquisition. Boot camps showcase the platform’s capabilities and demonstrate its adaptability across logistics, manufacturing, and supply chain management. Palantir’s core customer base comprises businesses seeking tailored AI/ML services, particularly large government and corporate clients willing to invest heavily in its systems.

AIP provides unified access to open-source, self-hosted, and commercial large language models (LLMs) that can transform structured and unstructured data into LLM-understandable objects and turn organizations' actions and processes into tools for humans and LLM-driven agents. This shift in the revenue structure has enabled PLTR to no longer depend on government defense agencies. 

Palantir Technologies has an expected revenue and earnings growth rate of 41.1% and 43%, respectively, for next year. The Zacks Consensus Estimate for next year’s earnings has improved 20.9% in the last 30 days.

The short-term average price target of brokerage firms for the stock represents an increase of 4.6% from the last closing price of $184.17. The brokerage target price is currently in the range of $50-$255. This indicates a maximum upside of 38.5% and a downside of 72.9%.

Fair Isaac Corp.Fair Isaac is benefiting from strong financial performance driven by robust growth in its Scores and Software segments. FICO has expanded its scoring models to incorporate ‘Buy Now, Pay Later’ loan data, enhancing the predictive accuracy of FICO scores. 

Advancements in credit modeling, including the development of FICO Score 10T for non-GSE mortgages, present significant growth opportunities. The Software segment has demonstrated strength, with increased adoption of SaaS and license revenues indicating strong platform engagement. FICO's Lenders Leading Inclusion Program supports lenders in making better decisions.

Fair Isaac has an expected revenue and earnings growth rate of 19.7% and 31.3%, respectively, for the current year (ending September 2026). The Zacks Consensus Estimate for current-year earnings has improved 3.6% in the last 30 days. 

The short-term average price target of brokerage firms for the stock represents an increase of 12% from the last closing price of $1,777.91. The brokerage target price is currently in the range of $1,047 to $2,400. This indicates a maximum upside of 35% and a downside of 41.1%.

Guidewire Software Inc.Guidewire Software is benefiting from the momentum of Guidewire Cloud, which continued into the fourth quarter of fiscal 2025. GWRE won 19 deals for its cloud platform, including nine with Tier 1 insurers. The 10-year Liberty Mutual deal, which is a key Tier 1 insurer, was highlighted by management as a milestone moment. 

GWRE is well-positioned to gain from deal wins momentum, especially among Tier 1 & Tier 2 insurers, healthy traction in the international belt and a durable subscription-driven revenue growth model. The Quantee buyout and traction for the Guidewire Industry Intelligence solution bode well. GWRE expects ARR to be $1.21-$1.22 billion. Increasing cloud infrastructure platform efficiency is cushioning its margins.

Guidewire Software has an expected revenue and earnings growth rate of 16.3% and 12.8%, respectively, for the current year (ending July 2026). The Zacks Consensus Estimate for current-year earnings has improved 1.7% in the last 60 days. 

The short-term average price target of brokerage firms for the stock represents an increase of 24.5% from the last closing price of $200.97. The brokerage target price is currently in the range of $160 to $305. This indicates a maximum upside of 51.8% and a downside of 20.4%.

The Zacks Chemicals Specialty industry is mired in demand weakness, largely due to sluggishness in Europe and a slow economic recovery in China, as well as disruptions from tariffs. Margins of companies in this space also remain under pressure due to the still-elevated input, supply chain and logistics costs.

Industry players, such as Perimeter Solutions, Inc. (PRM - Free Report) , Element Solutions Inc (ESI - Free Report) and Flexible Solutions International Inc. (FSI - Free Report) are banking on strategic measures, including operating cost reductions, to tide over a persistently challenging environment.

About the Industry
The Zacks Chemicals Specialty industry consists of manufacturers of specialty chemical products for a host of end-use markets such as textile, paper, automotive, electronics, personal care, energy, construction, food & beverages and agriculture. These chemicals (including catalysts, surfactants, specialty polymers, coating additives, pesticides and oilfield chemicals) are used based on their performance and have a specific purpose. Specialty chemicals can be single molecules or a combination of molecules referred to as formulations, and they provide a vast range of effects upon which various industries rely. Their compositions significantly influence the performance of the finished products. Specialty chemicals have applications in the manufacturing process of a vast range of products, including paints and coatings, cosmetics, petroleum products, inks and plastics. 

What's Shaping the Future of the Chemical Specialty Industry?
Demand Weakness Pose Headwinds: Companies in the chemical specialty space are facing headwinds from demand softness in building and construction as well as industrial end markets, especially in Europe and China, due to economic slowdown. Elevated borrowing costs and inflation have taken a bite out of the residential construction industry. Manufacturing activities have also weakened amid softer demand for goods and higher borrowing costs. A slower recovery in economic activities in China is hurting demand in that country. The prevailing geopolitical tension, low consumer confidence and high inflation have also dampened demand in Europe. While customer inventory de-stocking is essentially complete, some lingering impacts of the same in certain markets are expected to continue over the near term. The imposition of hefty tariffs has also introduced significant headwinds for the chemical specialty industry. The soft demand conditions, exacerbated by the weak macroeconomic environment and tariff-induced impacts, are likely to weigh on the volumes of chemical specialty companies.

Cost Pressure Still a Concern: Specialty chemical makers are facing headwinds from raw material and energy cost inflation, and supply-chain and freight transportation disruptions. Some companies are exposed to challenges from elevated logistics and labor costs. While raw material costs have moderated lately, driven by easing supply-chain disruptions, they remain higher than the pre-pandemic levels. Tariffs have also led to increased costs for raw materials, resulting in higher production expenses for the industry players. The lingering impacts of inflationary pressures are expected to continue over the short term and weigh on the margins of chemical specialty companies.

Self-help Actions to Support Results: The companies in this space are executing a raft of self-help measures — including cost-cutting and productivity improvement, expansion into high-growth markets, restructuring, operational efficiency improvement, and actions to strengthen the balance sheet and boost cash flows — in a bid to stay afloat amid the prevailing headwinds. The industry participants are aggressively implementing actions to cut costs. The measures are likely to help companies sail through the ongoing challenges.

Zacks Industry Rank Indicates Downbeat Prospects
The Zacks Chemicals Specialty industry is part of the broader Zacks Basic Materials sector. It carries a Zacks Industry Rank #178, which places it in the bottom 26% of more than 250 Zacks industries.

The group’s Zacks Industry Rank, which is basically the average of the Zacks Rank of all the member stocks, indicates a bleak near-term. Our research shows that the top 50% of the Zacks-ranked industries outperform the bottom 50% by a factor of more than 2 to 1.

Before we present a few stocks that you may want to consider for your portfolio, let’s take a look at the industry’s recent stock-market performance and valuation picture.

Industry Underperforms Sector & S&P 500
The Zacks Chemicals Specialty industry has underperformed the Zacks S&P 500 composite and the broader Zacks Basic Materials sector over the past year.

The industry has declined 10% over this period compared with the S&P 500’s rise of 16.8% and the broader sector’s increase of 11.9%.

One-Year Price PerformanceIndustry's Current Valuation
On the basis of the trailing 12-month enterprise value-to EBITDA (EV/EBITDA) ratio, which is a commonly used multiple for valuing chemical stocks, the industry is currently trading at 11.26X, below the S&P 500’s 18.6X and the sector’s 13.35X.

Over the past five years, the industry has traded as high as 14.19X, as low as 8.96X, with a median of 11.64X, as the chart below shows.

Enterprise Value/EBITDA (EV/EBITDA) Ratio

Enterprise Value/EBITDA (EV/EBITDA) Ratio 

3 Chemical Specialty Stocks to Keep a Close Eye on
Perimeter Solutions: Missouri-based Perimeter Solutions is a leading provider of solutions for the fire safety and specialty products industries. It is expected to benefit from the recovery of major end markets. Favorable industry trends are expected to continue to drive demand for fire-retardant products. The company remains focused on expanding its fire prevention and protection business. Its Specialty Products segment is seeing sales growth aided by a recovery from de-stocking activities and an increase in purchases by high-quality specialty chemicals customers. PRM’s strong balance sheet also offers adequate liquidity for growth investments and M&A opportunities.

Perimeter Solutions currently carries a Zacks Rank #1 (Strong Buy). It has expected earnings growth of 9.9% for 2025. The Zacks Consensus Estimate for PRM’s 2025 earnings has moved up 10.9% over the last 60 days. You can see the complete list of today’s Zacks #1 Rank stocks here.

Price and Consensus: PRM

Element Solutions: Florida-based Element Solutions is a leading specialty chemicals provider, offering innovative and differentiated solutions to its customers across a vast spectrum of industries. ESI is poised for growth, driven by strong execution and strategic positioning in the electronics sector, which underpins its robust long-term growth outlook. The company is benefiting from the strength in the electronics market. It is seeing strong organic growth in its Electronics segment, offsetting weakness in the industrial space. High-value end markets are contributing to a favorable product mix, while the ongoing pricing and productivity initiatives and lower raw material costs are boosting margins.

The consensus estimate for Element Solutions’ earnings for the current year has moved 1.4% upward over the last 60 days. ESI surpassed the Zacks Consensus Estimate in three of the trailing four quarters. It has a trailing four-quarter earnings surprise of roughly 2.7%, on average. ESI currently carries a Zacks Rank #3 (Hold).

Price and Consensus: ESI

Flexible Solutions: Canada-based Flexible Solutions specializes in biodegradable, water-soluble products as well as energy and water conservation products for drinking water, agriculture, and industrial markets. The company remains committed to exploring new opportunities in applications such as detergent, water treatment, oil field extraction and agriculture to further expand sales in the NanoChem division, which accounts for a significant portion of the company’s revenues. FSI's cash resources are also expected to be adequate to meet its cash flow requirements and future commitments. FSI is expanding its presence in the food and nutrition supplement manufacturing markets.

Flexible Solutions, carrying a Zacks Rank #3, has an expected earnings growth rate of 20.8% for 2025. The consensus estimate for FSI’s 2025 earnings has been stable over the last 60 days.

Price and Consensus: FSI

Novo Nordisk faces a shareholder backlash on Friday as the Danish drugmaker's minority investors prepare a protest vote against a board shake-up forced through by its dominant shareholder, the Novo Nordisk Foundation.

H&R Block (HRB - Free Report) has been beaten down lately with too much selling pressure. While the stock has lost 10.2% over the past four weeks, there is light at the end of the tunnel as it is now in oversold territory and Wall Street analysts expect the company to report better earnings than they predicted earlier.

We use Relative Strength Index (RSI), one of the most commonly used technical indicators, for spotting whether a stock is oversold. This is a momentum oscillator that measures the speed and change of price movements.

RSI oscillates between zero and 100. Usually, a stock is considered oversold when its RSI reading falls below 30.

Technically, every stock oscillates between being overbought and oversold irrespective of the quality of their fundamentals. And the beauty of RSI is that it helps you quickly and easily check if a stock's price is reaching a point of reversal.

So, by this measure, if a stock has gotten too far below its fair value just because of unwarranted selling pressure, investors may start looking for entry opportunities in the stock for benefiting from the inevitable rebound.

However, like every investing tool, RSI has its limitations, and should not be used alone for making an investment decision.

Here's Why HRB Could Experience a TurnaroundThe RSI reading of 29.09 for HRB is an indication that the heavy selling could be in the process of exhausting itself, so the stock could bounce back in a quest for reaching the old equilibrium of supply and demand.

The RSI value is not the only factor that indicates a potential turnaround for the stock in the near term. On the fundamental side, there has been strong agreement among the sell-side analysts covering the stock in raising earnings estimates for the current year. Over the last 30 days, the consensus EPS estimate for HRB has increased 0.1%. And an upward trend in earnings estimate revisions usually translates into price appreciation in the near term.

Moreover, HRB currently has a Zacks Rank #2 (Buy), which means it is in the top 20% of more than 4,000 stocks that we rank based on trends in earnings estimate revisions and EPS surprises. This is a more conclusive indication of the stock's potential turnaround in the near term. You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>> .

SummaryLantheus Holdings offers compelling value as a leading cancer diagnostic and treatment company, with a robust drug pipeline and defensive business model.
LNTH shares have dropped nearly 60% since March due to weaker sales, product pricing issues, and rising costs, compressing margins in 2025.
Despite recent challenges (or because of), Lantheus trades at a historically low valuation, with analysts forecasting improved earnings over the next 12-18 months.
A conservative balance sheet, underlying buying pressure in the stock, and takeover potential make LNTH an attractive pick for recession-resistant positioning.
Hiroshi Watanabe/DigitalVision via Getty Images

I have written on an expanding number of smaller medical product and pharmaceutical companies since the summertime. Decent valuations, stable operations during recession, and flight-to-safety investment characteristics make this area of the market a worthwhile hunting ground

Analyst’s Disclosure:I/we have a beneficial long position in the shares of LNTH, BMY, MRK either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

All opinions expressed herein are not investment recommendations and are not meant to be relied upon in investment decisions. The author is not acting in an investment advisor capacity and is not a registered investment advisor. The author recommends investors consult a qualified investment advisor before making any trade. Any projections, market outlooks, or estimates herein are forward-looking statements based upon certain assumptions that should not be construed as indicative of actual events that will occur. This article is not an investment research report but an opinion written at a point in time. The author's opinions expressed herein address only a small cross-section of data related to an investment in securities mentioned. Any analysis presented is based on incomplete information and is limited in scope and accuracy. The information and data in this article are obtained from sources believed to be reliable, but their accuracy and completeness are not guaranteed. The author expressly disclaims all liability for errors and omissions in the service and for the use or interpretation by others of information contained herein. Any and all opinions, estimates, and conclusions are based on the author's best judgment at the time of publication and are subject to change without notice. The author undertakes no obligation to correct, update, or revise the information in this document or to otherwise provide any additional materials. Past performance is no guarantee of future returns. Thanks for reading. Please consider this article a first step in your due diligence process. Consulting with a registered and experienced investment advisor is recommended before making any trade.

Seeking Alpha's Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

Recommended For You

TORONTO, Canada – TheNewswire - November 13, 2025 — SPARC AI Inc. (the “Company”) (CSE: SPAI) (OTCQB: SPAIF) (Frankfurt: 5OV0) SPARC AI announce that its Chief Executive Officer will attend the Military Communications and Information Systems Conference (MilCIS 2025). The event is held on 18-20 November in Canberra, Australia — the nation’s capital and a major hub for defence innovation and procurement.

MilCIS brings together senior defense officials, government agencies, and global industry leaders focused on next-generation military communications, digitisation, autonomous systems, and mission-critical technologies.

In addition to attending MilCIS, SPARC AI management will visit a discreet test location in Canbera where the Company is preparing for an upcoming drone demonstration featuring its proprietary GPS-denied target acquisition and autonomous navigation technologies. The demonstration will showcase real-world performance of SPARC AI’s Overwatch software, including long-range geolocation, and autonomous flight capabilities.

“MilCIS provides an opportunity to engage directly with defence stakeholders, integrators, and potential partners, while our private demonstration will allow select end-users to see Overwatch’s capabilities in a live, operational setting.” said CEO, Anoosh Manzoori

About SPARC AI Inc.

SPARC AI Inc. develops next-generation, GPS-free target acquisition and intelligence software for drones and edge devices. Its zero-signature technology delivers real-time detection, tracking, and behavioral insights without reliance on radar, lidar, or heavy sensors. SPARC AI’s flagship platform, provides defence, rescue, first responders, and commercial operators with unmatched situational awareness. The Company is committed to building a scalable software platform that defines the future of drone intelligence globally.

For further information contact:

Anoosh Manzoori, Chief Executive Officer

SPARC AI Inc.

E-mail: [email protected]

Web: www.sparcai.co

Tel: (213) 459-3994

Cautionary Statement Regarding Forward-Looking Statements

This news release contains “forward-looking statements” or “forward-looking information” (collectively, “forward-looking statements”) within the meaning of applicable securities legislation. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates and projections as of the date of this news release. Forward-looking statements include, but are not limited to, statements regarding: the expected timing for completion of the Offering and the intended use of proceeds.

Forward-looking statements are subject to a variety of known and unknown risks, uncertainties and other factors that could cause actual events or results to differ from those expressed or implied by forward-looking statements contained herein. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Certain important factors that could cause actual results, performance or achievements to differ materially from those in the forward-looking statements are highlighted in the “Risks and Uncertainties” in the Company’s management discussion and analysis.

Forward-looking statements are based upon a number of estimates and assumptions that, while considered reasonable by the Company at this time, are inherently subject to significant business, economic and competitive uncertainties and contingencies that may cause the Company’s actual financial results, performance, or achievements to be materially different from those expressed or implied herein. Some of the material factors or assumptions used to develop forward-looking statements include, without limitation: the failure to complete the Offering; reliance on key management and other personnel; potential downturns in economic conditions; competition from others; market factors, including future demand products developed by the Company; the policies and actions of foreign governments, which could impact the ability of the Company to successfully market its products; the Company’s expectations in connection with the development of the Target Acquisition System; the effectiveness of the Target Acquisition System; changes in national and local government legislation, taxation, controls or regulations and/or changes in the administration or laws, policies and practices; the impact of general business and economic conditions; currency exchange rates; and the impact of inflation.

The forward-looking statements contained in this news release are expressly qualified by this cautionary statement. Any forward-looking statements and the assumptions made with respect thereto are made as of the date of this news release and, accordingly, are subject to change after such date. The Company disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise, except as may be required by applicable securities laws. There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements.

NEW YORK, Nov. 13, 2025 (GLOBE NEWSWIRE) -- Creatd, Inc. (OTCQB: CRTD) (“Creatd” or the “Company”) today announced that, as part of its strategic initiative to uplist to a national securities exchange, the Company has engaged Dawson James Securities, Inc. as its financial advisor and Lucosky Brookman LLP as legal counsel to advise on the transaction. CEO Jeremy Frommer commented: “We are fully committed to the uplisting process and to positioning Created for long-term growth.